![Jason Kneeland](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Kneeland
No más puestos en curso
Perfil
Jason Kneeland worked as Vice President-Finance at TechTarget Holdings, Inc. from 2013 to 2017.
Prior to that, served as Senior Manager at Corporate Finance Group, Inc. from 2012 to 2013.
Also held the position of Vice President-Finance & Controller at Acer Therapeutics, Inc. Education includes an undergraduate degree from Johnson & Wales University, Inc.
Antiguos cargos conocidos de Jason Kneeland.
| Empresas | Cargo | Fin |
|---|---|---|
| TECHTARGET, INC. | Corporate Officer/Principal | 01/11/2017 |
Corporate Finance Group, Inc.
 Corporate Finance Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides accounting, tax, business advisory and cybersecurity services | Corporate Officer/Principal | 01/08/2013 |
| ACER THERAPEUTICS INC. | Comptroller/Controller/Auditor | - |
Formación de Jason Kneeland.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
8
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
TechTarget Holdings, Inc.
 TechTarget Holdings, Inc. Internet Software/ServicesTechnology Services Operates as a B2B tech sales and marketing platform | Technology Services |
Johnson & Wales University, Inc.
 Johnson & Wales University, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corporate Finance Group, Inc.
Corporate Finance Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides accounting, tax, business advisory and cybersecurity services | Commercial Services |
Acer Therapeutics, Inc.
 Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes therapies for serious rare and life-threatening diseases | Health Technology |
- Bolsa de valores
- Insiders
- Jason Kneeland
